NCT06875700 Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
| NCT ID | NCT06875700 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Leiomyosarcoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-07-09 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-07-09 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Genomic research has shown that a portion of leiomyosarcomas can be attributed to an underlying cancer predisposition syndrome. However, the optimal approach for incorporating germline testing into the care of these patients. This study is assessing the beliefs about the heritability of leiomyosarcoma and other cancer risks, and attitudes towards germline testing among leiomyosarcoma patients.
Eligibility Criteria
Inclusion LMS Proband * Actionable germline PV detected in the research context * Living * No prior germline testing for this PV * Able to speak and read English * Mentally competent * Age 18 or older Relative of LMS Proband * 25-50% chance for having inherited the PV * No prior germline testing for this PV * Able to speak and read English * Mentally competent * Age 18 or older Exclusion (both cohorts) * \<18 years * Unable to read or write
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06875700 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Leiomyosarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06875700 currently recruiting?
Yes, NCT06875700 is actively recruiting participants. Contact the research team at gregg.wood@hci.utah.edu for enrollment information.
Where is the NCT06875700 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT06875700 clinical trial?
NCT06875700 is sponsored by University of Utah. The trial plans to enroll 300 participants.